Matinas BioPharma 收到不符合 NYSE American 持续上市标准通知 并提交恢复合规计划获接纳

美股速递
Jun 27

Matinas BioPharma Holdings, Inc (MTNB) 已收到纽约证券交易所美国公司(NYSE American)发出的通知,指出其当前未能符合该交易所的持续上市标准。与此同时,该公司提交的旨在恢复合规状态的计划已获得交易所接纳。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10